forecast
Regulation Keeps M&A in Hands of Incumbents
Because nicotine products increasingly require FDA or other regulatory approval, new entrants face high barriers, so the industry will be dominated by well-funded incumbents that can navigate approvals, and Evan expects little M&A from here.
forecastpending
Speaker
EvanEvidence Quote
“I think it's going to continue to be dominated by the companies that have the money and the time and the regulatory prowess”
Created: 11/17/2026, 4:57:50 PM
Your notes
Loading notes...